Literature DB >> 29393220

Population-Based Cohort Study on Dementia Risk in Patients with Type 1 Diabetes Mellitus.

Chia-Lun Kuo1,2, Chin-Li Lu2, Ya-Hui Chang2, Chung-Yi Li2,3.   

Abstract

BACKGROUND: The risk of dementia increases by 15-28% in patients with type 2 diabetes mellitus (DM). However, studies on dementia risk in type 1 DM have been neither comprehensive nor conclusive.
METHODS: We carried out a cohort study involving 1,077 patients registered to have type 1 DM from 1998 to 2009 and 32,310 matched non-DM controls who were selected from Taiwan National Health Insurance Claims. These participants were followed up from their first clinical appearance for type 1 DM treatment in 1998-2009 to the date of dementia diagnosis or the last day of 2011. The Cox proportional hazard model was employed to estimate the hazard ratio (HR) of dementia incidence.
RESULTS: The incidence rates of dementia reached 42.8 and 13.1 per 104 person-years for the type 1 DM and control groups respectively. The adjusted HR of dementia in patients with type 1 DM was estimated at 3.01 (95% CI 2.18-4.14) after adjustment for demographics, comorbidity, urbanization, monthly income, and annual frequency of ambulatory care visits. No significant difference in sex-specific HR was observed.
CONCLUSIONS: The relative risk of developing dementia (118-314%) in patients with type 1 DM was much higher than the -previously reported relative risk (15-28%) associated with type 2 DM.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Cohort studies; Dementia; Incidence; Type 1 diabetes

Mesh:

Year:  2018        PMID: 29393220     DOI: 10.1159/000486719

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

1.  Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors.

Authors:  Joshua S Talboom; Asta Håberg; Matthew D De Both; Marcus A Naymik; Isabelle Schrauwen; Candace R Lewis; Stacy F Bertinelli; Callie Hammersland; Mason A Fritz; Amanda J Myers; Meredith Hay; Carol A Barnes; Elizabeth Glisky; Lee Ryan; Matthew J Huentelman
Journal:  Elife       Date:  2019-06-18       Impact factor: 8.140

2.  Sex, diabetes status and cognition: findings from the study of longevity in diabetes.

Authors:  Chris Moran; Paola Gilsanz; Michal S Beeri; Rachel A Whitmer; Mary E Lacy
Journal:  BMJ Open Diabetes Res Care       Date:  2021-01

3.  Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose.

Authors:  I K Wium-Andersen; J Rungby; M B Jørgensen; A Sandbæk; M Osler; M K Wium-Andersen
Journal:  Epidemiol Psychiatr Sci       Date:  2019-08-28       Impact factor: 6.892

4.  Comparison of cognitive function in older adults with type 1 diabetes, type 2 diabetes, and no diabetes: results from the Study of Longevity in Diabetes (SOLID).

Authors:  Mary E Lacy; Chris Moran; Paola Gilsanz; Michal S Beeri; Andrew J Karter; Rachel A Whitmer
Journal:  BMJ Open Diabetes Res Care       Date:  2022-03

5.  Immune-mediated diseases are associated with a higher incidence of dementia: a prospective cohort study of 375,894 individuals.

Authors:  Ya-Ru Zhang; Liu Yang; Hui-Fu Wang; Bang-Sheng Wu; Shu-Yi Huang; Wei Cheng; Jian-Feng Feng; Jin-Tai Yu
Journal:  Alzheimers Res Ther       Date:  2022-09-13       Impact factor: 8.823

6.  Association of Type 1 Diabetes and Hypoglycemic and Hyperglycemic Events and Risk of Dementia.

Authors:  Rachel A Whitmer; Paola Gilsanz; Charles P Quesenberry; Andrew J Karter; Mary E Lacy
Journal:  Neurology       Date:  2021-06-02       Impact factor: 11.800

7.  Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats.

Authors:  Shiva Ebrahimpour; Abolghasem Esmaeili; Siamak Beheshti
Journal:  Int J Nanomedicine       Date:  2018-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.